- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Repurposing the yellow fever vaccine for intratumoral immunotherapy ; volume:12 ; number:1 ; year:2020 ; extent:17
EMBO molecular medicine / European Molecular Biology Organization ; 12, Heft 1 (2020) (gesamt 17)
- Creator
-
Aznar, Maria Angela
Molina, Carmen
Teijeira, Alvaro
Rodriguez, Inmaculada
Azpilikueta, Arantza
Garasa, Saray
Sanchez‐Paulete, Alfonso R.
Cordeiro, Luna
Etxeberria, Iñaki
Alvarez, Maite
Rius‐Rocabert, Sergio
Nistal‐Villan, Estanislao
Berraondo, Pedro
Melero, Ignacio
- DOI
-
10.15252/emmm.201910375
- URN
-
urn:nbn:de:101:1-2022062807250618625166
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Aznar, Maria Angela
- Molina, Carmen
- Teijeira, Alvaro
- Rodriguez, Inmaculada
- Azpilikueta, Arantza
- Garasa, Saray
- Sanchez‐Paulete, Alfonso R.
- Cordeiro, Luna
- Etxeberria, Iñaki
- Alvarez, Maite
- Rius‐Rocabert, Sergio
- Nistal‐Villan, Estanislao
- Berraondo, Pedro
- Melero, Ignacio
Other Objects (12)
Intratumoral immunotherapy with the TLR7/8 agonist 3M-052
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
Facile repurposing of peptide–MHC-restricted antibodies for cancer immunotherapy
mRNA vaccine for cancer immunotherapy
Neoantigen vaccine: an emerging tumor immunotherapy
Diphtheria Toxoid Particles as Q Fever Vaccine
Cytoreduction surgery reduces systemic myeloid suppressor cell populations and restores intratumoral immunotherapy effectiveness
Drug repurposing
Synergistic combination therapy using cowpea mosaic virus intratumoral immunotherapy and Lag-3 checkpoint blockade
Intratumoral pro-oxidants promote cancer immunotherapy by recruiting and reprogramming neutrophils to eliminate tumors
Genetic sequencing of a 1944 Rocky Mountain spotted fever vaccine
Dexosomes as a cell-free vaccine for cancer immunotherapy
Intratumoral immunotherapy with the TLR7/8 agonist 3M-052
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
Facile repurposing of peptide–MHC-restricted antibodies for cancer immunotherapy
mRNA vaccine for cancer immunotherapy
Neoantigen vaccine: an emerging tumor immunotherapy
Diphtheria Toxoid Particles as Q Fever Vaccine
Cytoreduction surgery reduces systemic myeloid suppressor cell populations and restores intratumoral immunotherapy effectiveness
Drug repurposing
Synergistic combination therapy using cowpea mosaic virus intratumoral immunotherapy and Lag-3 checkpoint blockade
Intratumoral pro-oxidants promote cancer immunotherapy by recruiting and reprogramming neutrophils to eliminate tumors
Genetic sequencing of a 1944 Rocky Mountain spotted fever vaccine
Dexosomes as a cell-free vaccine for cancer immunotherapy
Intratumoral immunotherapy with the TLR7/8 agonist 3M-052
Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
Facile repurposing of peptide–MHC-restricted antibodies for cancer immunotherapy
mRNA vaccine for cancer immunotherapy
Neoantigen vaccine: an emerging tumor immunotherapy
Diphtheria Toxoid Particles as Q Fever Vaccine
Cytoreduction surgery reduces systemic myeloid suppressor cell populations and restores intratumoral immunotherapy effectiveness
Drug repurposing
Synergistic combination therapy using cowpea mosaic virus intratumoral immunotherapy and Lag-3 checkpoint blockade
Intratumoral pro-oxidants promote cancer immunotherapy by recruiting and reprogramming neutrophils to eliminate tumors
Genetic sequencing of a 1944 Rocky Mountain spotted fever vaccine